A Phase I Study of HS-20093 Injection in Combination Therapy in Non-Small Cell Lung Cancer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a multicenter, open-label, Phase 1 clinical study to evaluate the efficacy and safety of HS-20093 combination therapy in subjects with advanced or metastatic non-small cell lung cancer without actionable genomic alterations.
Epistemonikos ID: b1848e51fc4f7472eca0c6e47de3a119ad20c58a
First added on: Oct 28, 2026